Related content

Phase I and II clinical trials of trastuzumab

By Baselga J.  

Annals of Oncology, Vol. 12, Iss. 12, 2001-12 ,pp. : 49-55

Springer Publishing Company

Access to resources Recommend Favorite

Comparative pharmacokinetics of subcutaneous trastuzumab administered via handheld syringe or proprietary single-use injection device in healthy males

By Wynne Chris   Ellis-Pegler Rod   Waaka Devonie   Schwabe Christian   Lehle Michaela   Heinzmann Dominik   Mangat Ranvir   Li Chunze   Dick Anne   Cranshaw Nicola   Lum Bert  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 5, 2013-11 ,pp. : 1079-1087

Springer Publishing Company

Access to resources Recommend Favorite

Leuprorelin: Subcutaneous Depot Formulation (Eligard®) for Advanced Prostate Cancer

By Evans Hannah C.   Wagstaff Antona J.  

American Journal of Cancer, Vol. 3, Iss. 3, 2004-01 ,pp. : 197-201

Adis International

Access to resources Recommend Favorite

International Meeting “Immunotherapy of Cancer: Challenges and Needs”

By Ferrantini Maria   Capone Imerio   Marincola Francesco   Parmiani Giorgio   Belardelli Filippo  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 4, 2007-04 ,pp. : 581-585

Springer Publishing Company

Access to resources Recommend Favorite

Two Cases of Endometrial Cancer Meeting New Clinical Criteria for Hereditary Nonpolyposis Colorectal Cancer

By Sagawa T.   Yamada H.   Yamamoto R.   Sakuragi N.   Fujimoto S.  

Gynecologic Oncology, Vol. 79, Iss. 2, 2000-11 ,pp. : 327-331

Elsevier

Access to resources Recommend Favorite